{"latest_checked": "2026-08-03T11:12:42.264912+00:00", "coverage_count": 5079, "recent_count": 143, "transaction_limit": 160, "filters": {"q": "", "ticker": "NUVL", "sector": "", "industry": "", "side": "", "start": "2026-06-19", "end": "2026-08-03"}, "summary": {"total": 143, "acquisition_count": 13, "disposal_count": 130, "acquisition_value": 2048092.22, "acquisition_value_label": "$2.0M", "disposal_value": 1504296765.31, "disposal_value_label": "$1.5B", "net_value": -1502248673.09, "net_value_label": "$-1.5B", "flow_tone": "negative", "largest_value_label": "$1.0B", "top_sector": "Healthcare", "window_label": "19 Jun 2026 to 03 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 143, "value": "1506344857.5300", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$1.5B"}], "days": [{"transaction_date": "2026-06-29", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 2.4}, {"transaction_date": "2026-07-01", "acquisitions": 4, "disposals": 6, "total": 10, "bar_width": 7.9}, {"transaction_date": "2026-07-06", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 2.4}, {"transaction_date": "2026-07-09", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 0.8}, {"transaction_date": "2026-07-15", "acquisitions": 7, "disposals": 119, "total": 126, "bar_width": 100.0}], "side_mix": {"acquisitions": 13, "disposals": 130, "acquisition_share": 9.1, "disposal_share": 90.9}}, "company_flows": [{"symbol": "NUVL", "name": "Nuvalent Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-15", "acquisitions": 13, "disposals": 29, "acquired_value": 2048092.22, "acquired_value_label": "$2.0M", "disposed_value": 1504296765.31, "disposed_value_label": "$1.5B", "net_value": -1502248673.09, "net_value_label": "$-1.5B", "acquisition_share": 31.0, "disposal_share": 69.0, "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}], "company_overview": [{"symbol": "NUVL", "name": "Nuvalent Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-15", "filings": 143, "acquisitions": 13, "disposals": 130, "acquired_value": 2048092.22, "acquired_value_label": "$2.0M", "disposed_value": 1504296765.31, "disposed_value_label": "$1.5B", "net_value": -1502248673.09, "net_value_label": "$-1.5B", "acquisition_share": 9.1, "disposal_share": 90.9, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}], "transactions": [{"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Class A Common Stock - Performance Stock Units", "side_code": "D", "side": "Disposal", "shares": 14350.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.914782+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 131637.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.913327+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 8016.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.911937+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 22933.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.910575+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 84200.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.909147+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 33646.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.033531+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 37500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.032197+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 17500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.030820+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 41100.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.917516+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BOGLE, GRANT C.", "executive_title": "Director", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 5577.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.868526+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BOGLE, GRANT C.", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 4851.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.869891+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BOGLE, GRANT C.", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 4147.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.871280+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "FLYNN, JAMES E", "executive_title": "Director, 10% Owner, Director by Deputization", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 20000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.933888+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "FLYNN, JAMES E", "executive_title": "Director, 10% Owner, Director by Deputization", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 15000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.932528+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "FLYNN, JAMES E", "executive_title": "Director, 10% Owner, Director by Deputization", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 4147.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.929824+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "FLYNN, JAMES E", "executive_title": "Director, 10% Owner, Director by Deputization", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 3789.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.931182+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "FLYNN, JAMES E", "executive_title": "Director, 10% Owner, Director by Deputization", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 43000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.935272+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "LANE, BENJAMIN", "executive_title": "See Remarks", "security_type": "Class A Common Stock - Performance Stock Units", "side_code": "D", "side": "Disposal", "shares": 7120.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.961630+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "LANE, BENJAMIN", "executive_title": "See Remarks", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 29433.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.964319+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "LANE, BENJAMIN", "executive_title": "See Remarks", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 12025.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.954517+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "LANE, BENJAMIN", "executive_title": "See Remarks", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 731.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.960162+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "LANE, BENJAMIN", "executive_title": "See Remarks", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 8000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.985805+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "LANE, BENJAMIN", "executive_title": "See Remarks", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 15052.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.955816+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "LANE, BENJAMIN", "executive_title": "See Remarks", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 17848.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.957241+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "LANE, BENJAMIN", "executive_title": "See Remarks", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 8333.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.958761+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "LANE, BENJAMIN", "executive_title": "See Remarks", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 19000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.984446+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MEYERS, MICHAEL L.", "executive_title": "Director", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 3444.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.927006+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MEYERS, MICHAEL L.", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 8361.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.925693+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MEYERS, MICHAEL L.", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 40000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.924362+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MEYERS, MICHAEL L.", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 15000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.922996+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MEYERS, MICHAEL L.", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 3789.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.921608+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MEYERS, MICHAEL L.", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 4147.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.920283+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MILLER, DEBORAH ANN", "executive_title": "Chief Legal Officer", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 41100.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.886640+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MILLER, DEBORAH ANN", "executive_title": "Chief Legal Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 17500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.858430+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MILLER, DEBORAH ANN", "executive_title": "Chief Legal Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 37500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.861579+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MILLER, DEBORAH ANN", "executive_title": "Chief Legal Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 47500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.864366+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MILLER, DEBORAH ANN", "executive_title": "Chief Legal Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 75154.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.865827+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MILLER, DEBORAH ANN", "executive_title": "Chief Legal Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 61000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.874147+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MILLER, DEBORAH ANN", "executive_title": "Chief Legal Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 72608.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.875605+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MILLER, DEBORAH ANN", "executive_title": "Chief Legal Officer", "security_type": "Class A Common Stock - Performance Stock Units", "side_code": "D", "side": "Disposal", "shares": 14350.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.877142+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 21259.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.989910+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 15112.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.991306+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 6091.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.992596+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 216.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.994019+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Class A Common Stock - Performance Stock Units", "side_code": "D", "side": "Disposal", "shares": 14350.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.995425+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 41100.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.998079+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 17500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.967250+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 81329.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.971657+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 33646.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.970143+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 37500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.968677+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "OLIGER, CHRISTY J.", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 6119.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.019588+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "OLIGER, CHRISTY J.", "executive_title": "Director", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 6091.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.020923+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PELISH, HENRY E.", "executive_title": "Chief Scientific Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 17500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.907779+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PELISH, HENRY E.", "executive_title": "Chief Scientific Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 18600.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.943348+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PELISH, HENRY E.", "executive_title": "Chief Scientific Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 9900.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.946161+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PELISH, HENRY E.", "executive_title": "Chief Scientific Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 37500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.856082+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PELISH, HENRY E.", "executive_title": "Chief Scientific Officer", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 41100.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.953003+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PELISH, HENRY E.", "executive_title": "Chief Scientific Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 3258.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.981674+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PELISH, HENRY E.", "executive_title": "Chief Scientific Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 2113.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.948984+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PELISH, HENRY E.", "executive_title": "Chief Scientific Officer", "security_type": "Class A Common Stock - Performance Stock Units", "side_code": "D", "side": "Disposal", "shares": 14350.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.950317+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PELISH, HENRY E.", "executive_title": "Chief Scientific Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 21073.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.944791+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PELISH, HENRY E.", "executive_title": "Chief Scientific Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 8309.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.947611+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 508942.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.900989+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Class A Common Stock - Performance Stock Units", "side_code": "D", "side": "Disposal", "shares": 40025.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.902355+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 121350.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.905031+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 49401.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.899673+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 33423.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.898305+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 867172.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.896946+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 118686.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.895645+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 131494.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.894211+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 161100.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.892637+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 112500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.891285+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 46250.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.889819+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PROTOPAPAS, ANNA", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 4147.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.862915+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PROTOPAPAS, ANNA", "executive_title": "Director", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 3444.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.980280+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PROTOPAPAS, ANNA", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 40000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.978833+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PROTOPAPAS, ANNA", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 15000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.977384+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PROTOPAPAS, ANNA", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 3789.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.975972+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "SQUARER, RON", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 4418.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.016906+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "SQUARER, RON", "executive_title": "Director", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 6281.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.018265+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "SRIVASTAVA, SAPNA", "executive_title": "Director", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 3444.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.028050+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "SRIVASTAVA, SAPNA", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 20000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.987194+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "SRIVASTAVA, SAPNA", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 15000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.026607+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "SRIVASTAVA, SAPNA", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 3789.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.025179+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "SRIVASTAVA, SAPNA", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 4147.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.023788+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "SRIVASTAVA, SAPNA", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 68500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.988574+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "TURNER, CHRISTOPHER DURANT", "executive_title": "Chief Medical Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 47500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.003852+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "TURNER, CHRISTOPHER DURANT", "executive_title": "Chief Medical Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 37500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.002243+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "TURNER, CHRISTOPHER DURANT", "executive_title": "Chief Medical Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 17500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.000862+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "TURNER, CHRISTOPHER DURANT", "executive_title": "Chief Medical Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 144200.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.005344+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "TURNER, CHRISTOPHER DURANT", "executive_title": "Chief Medical Officer", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 41100.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.014192+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "TURNER, CHRISTOPHER DURANT", "executive_title": "Chief Medical Officer", "security_type": "Class A Common Stock - Performance Stock Units", "side_code": "D", "side": "Disposal", "shares": 14350.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.011356+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "TURNER, CHRISTOPHER DURANT", "executive_title": "Chief Medical Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 303105.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.009986+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "TURNER, CHRISTOPHER DURANT", "executive_title": "Chief Medical Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 2835.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.008396+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "TURNER, CHRISTOPHER DURANT", "executive_title": "Chief Medical Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 107000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:14.006939+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "WHEELER, CAMERON", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 15000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.974454+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "WHEELER, CAMERON", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 4147.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.973013+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "WHEELER, CAMERON", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 43000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.885156+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "WHEELER, CAMERON", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 20000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.883632+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "WHEELER, CAMERON", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 3789.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.882019+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "WHEELER, CAMERON", "executive_title": "Director", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 3444.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-21T22:04:13.880459+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "FLYNN, JAMES E", "executive_title": "Director, 10% Owner, Director by Deputization", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 8299225.0, "share_price": 124.0, "transaction_value": 1029103900.0, "fetched_at": "2026-07-21T22:04:13.941943+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "FLYNN, JAMES E", "executive_title": "Director, 10% Owner, Director by Deputization", "security_type": "Class B Common Stock", "side_code": "D", "side": "Disposal", "shares": 2717627.0, "share_price": 124.0, "transaction_value": 336985748.0, "fetched_at": "2026-07-21T22:04:13.936598+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "FLYNN, JAMES E", "executive_title": "Director, 10% Owner, Director by Deputization", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 650000.0, "share_price": 124.0, "transaction_value": 80600000.0, "fetched_at": "2026-07-21T22:04:13.940595+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 203529.0, "share_price": 124.0, "transaction_value": 25237596.0, "fetched_at": "2026-07-21T22:04:13.906370+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 44433.0, "share_price": 124.0, "transaction_value": 5509692.0, "fetched_at": "2026-07-21T22:04:13.918891+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "TURNER, CHRISTOPHER DURANT", "executive_title": "Chief Medical Officer", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 31530.0, "share_price": 124.0, "transaction_value": 3909720.0, "fetched_at": "2026-07-21T22:04:14.015551+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PELISH, HENRY E.", "executive_title": "Chief Scientific Officer", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 22393.0, "share_price": 124.0, "transaction_value": 2776732.0, "fetched_at": "2026-07-21T22:04:13.983072+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "LANE, BENJAMIN", "executive_title": "See Remarks", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 21092.0, "share_price": 124.0, "transaction_value": 2615408.0, "fetched_at": "2026-07-21T22:04:13.965742+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MILLER, DEBORAH ANN", "executive_title": "Chief Legal Officer", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 18534.0, "share_price": 124.0, "transaction_value": 2298216.0, "fetched_at": "2026-07-21T22:04:13.888113+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 17017.0, "share_price": 124.0, "transaction_value": 2110108.0, "fetched_at": "2026-07-21T22:04:13.999516+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "FLYNN, JAMES E", "executive_title": "Director, 10% Owner, Director by Deputization", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 5146.0, "share_price": 124.0, "transaction_value": 638104.0, "fetched_at": "2026-07-21T22:04:13.939275+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MEYERS, MICHAEL L.", "executive_title": "Director", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 5146.0, "share_price": 124.0, "transaction_value": 638104.0, "fetched_at": "2026-07-21T22:04:13.928362+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PROTOPAPAS, ANNA", "executive_title": "Director", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 5146.0, "share_price": 124.0, "transaction_value": 638104.0, "fetched_at": "2026-07-21T22:04:13.860189+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "SRIVASTAVA, SAPNA", "executive_title": "Director", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 5146.0, "share_price": 124.0, "transaction_value": 638104.0, "fetched_at": "2026-07-21T22:04:14.029420+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "WHEELER, CAMERON", "executive_title": "Director", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 5146.0, "share_price": 124.0, "transaction_value": 638104.0, "fetched_at": "2026-07-21T22:04:13.872684+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BOGLE, GRANT C.", "executive_title": "Director", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 3714.0, "share_price": 124.0, "transaction_value": 460536.0, "fetched_at": "2026-07-21T22:04:13.867184+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "FLYNN, JAMES E", "executive_title": "Director, 10% Owner, Director by Deputization", "security_type": "Class A Common Stock - Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 3444.0, "share_price": 124.0, "transaction_value": 427056.0, "fetched_at": "2026-07-21T22:04:13.937930+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "OLIGER, CHRISTY J.", "executive_title": "Director", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 1324.0, "share_price": 124.0, "transaction_value": 164176.0, "fetched_at": "2026-07-21T22:04:14.022263+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Class A Common Stock - Performance Stock Units", "side_code": "A", "side": "Acquisition", "shares": 14350.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:13.916141+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "LANE, BENJAMIN", "executive_title": "See Remarks", "security_type": "Class A Common Stock - Performance Stock Units", "side_code": "A", "side": "Acquisition", "shares": 7120.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:13.962932+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "MILLER, DEBORAH ANN", "executive_title": "Chief Legal Officer", "security_type": "Class A Common Stock - Performance Stock Units", "side_code": "A", "side": "Acquisition", "shares": 14350.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:13.878795+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Class A Common Stock - Performance Stock Units", "side_code": "A", "side": "Acquisition", "shares": 14350.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:13.996750+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PELISH, HENRY E.", "executive_title": "Chief Scientific Officer", "security_type": "Class A Common Stock - Performance Stock Units", "side_code": "A", "side": "Acquisition", "shares": 14350.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:13.951716+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Class A Common Stock - Performance Stock Units", "side_code": "A", "side": "Acquisition", "shares": 40025.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:13.903667+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "TURNER, CHRISTOPHER DURANT", "executive_title": "Chief Medical Officer", "security_type": "Class A Common Stock - Performance Stock Units", "side_code": "A", "side": "Acquisition", "shares": 14350.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:14.012775+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-09", "executive": "PELISH, HENRY E.", "executive_title": "Chief Scientific Officer", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 2111.0, "share_price": 123.81, "transaction_value": 261362.91, "fetched_at": "2026-07-21T22:04:14.034937+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 30000.0, "share_price": 123.72, "transaction_value": 3711600.0, "fetched_at": "2026-07-21T22:04:14.038733+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Class A Common Stock", "side_code": "A", "side": "Acquisition", "shares": 30000.0, "share_price": 18.93, "transaction_value": 567900.0, "fetched_at": "2026-07-21T22:04:14.036272+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "PORTER, JAMES RICHARD", "executive_title": "Director, President and CEO", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 30000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:14.037507+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 23000.0, "share_price": 123.59, "transaction_value": 2842570.0, "fetched_at": "2026-07-21T22:04:14.042447+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 11430.0, "share_price": 123.58, "transaction_value": 1412519.4, "fetched_at": "2026-07-21T22:04:14.051387+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Class A Common Stock", "side_code": "A", "side": "Acquisition", "shares": 13854.0, "share_price": 72.35, "transaction_value": 1002336.9, "fetched_at": "2026-07-21T22:04:14.043763+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Class A Common Stock", "side_code": "A", "side": "Acquisition", "shares": 9146.0, "share_price": 18.93, "transaction_value": 173133.78, "fetched_at": "2026-07-21T22:04:14.047565+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Class A Common Stock", "side_code": "A", "side": "Acquisition", "shares": 6046.0, "share_price": 18.93, "transaction_value": 114450.78, "fetched_at": "2026-07-21T22:04:14.039934+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Class A Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5384.0, "share_price": 6.89, "transaction_value": 37095.76, "fetched_at": "2026-07-21T22:04:14.048793+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 6046.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:14.044990+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "BALCOM, ALEXANDRA", "executive_title": "Chief Financial Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 5384.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:14.050106+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 9146.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:14.046384+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 13854.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:14.041231+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 5500.0, "share_price": 123.51, "transaction_value": 679305.0, "fetched_at": "2026-07-20T10:54:44.370939+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Class A Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5500.0, "share_price": 27.85, "transaction_value": 153175.0, "fetched_at": "2026-07-20T10:54:44.375380+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}, {"symbol": "NUVL", "name": "Nuvalent Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "NOCI, DARLENE", "executive_title": "Chief Development Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 5500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-20T10:54:44.373260+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nuvl/", "research_links": {"chart": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/", "report": "/terminal/6e03991b-5289-49bd-8f4a-2d4be29f95b7/report/", "factor": "/factors/ticker/6e03991b-5289-49bd-8f4a-2d4be29f95b7/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}